SCHEMBL7352131

SCHEMBL7352131

COc1ccc2c(c1)CCC(NC(=O)C(C)C)C2

nearest known ligand 0.70

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.70
CA2 P00918 5/20 0.70
ACHE P22303 5/20 0.70
MTNR1A P48039 5/20 0.67
MTNR1B P49286 4/20 0.67
NQO2 P16083 1/20 0.52
DRD2 P14416 3/20 0.50
DRD3 P35462 2/20 0.50
DRD4 P21917 2/20 0.47
CYP26A1 O43174 1/20 0.45
TAOK1 Q7L7X3 1/20 0.45
TAOK3 Q9H2K8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3975748 0.85 MTNR1A (0.90) CA1CA2ACHEMTNR1AMTNR1B
SCHEMBL11852239 0.83 CA1 (0.60) CA1CA2ACHEMTNR1AMTNR1B
SCHEMBL7337809 0.82 CA1 (0.70) CA1CA2ACHEMTNR1AMTNR1B
SCHEMBL7210331 0.82 CA1 (0.70) CA1CA2ACHEMTNR1AMTNR1B
SCHEMBL3854031 0.80 MTNR1A (1.00) CA1CA2ACHEMTNR1AMTNR1B
SCHEMBL5783028 0.80 CA1 (0.67) CA1CA2ACHEMTNR1AMTNR1B
SCHEMBL26763719 0.79 MTNR1A (0.69) CA1CA2MTNR1AMTNR1BTAOK1
Hydrochloric Acid SCHEMBL11488623 0.79 CA1 (0.59) CA1CA2ACHEMTNR1AMTNR1B
SCHEMBL3395108 0.78 CA1 (0.64) CA1CA2ACHEMTNR1AMTNR1B
SCHEMBL8624827 0.78 CA1 (0.64) CA1CA2ACHEMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0971878-A1 AMINE COMPOUNDS, THEIR PRODUCTION AND USE AS AMYLOID-BETA PRODUCTION INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2000-01-19 EP disclosed
WO-1998038156-A1 AMINE COMPOUNDS, THEIR PRODUCTION AND USE AS AMYLOID-BETA PRODUCTION INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-09-03 WO disclosed